JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) En Espanol Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quang-Cantagrel, N. D. Articles by Magnuson, S. K. Search for Related Content PubMed PubMed Citation Articles by Quang-Cantagrel, N. D. Articles by Magnuson, S. K.

---

REGIONAL ANESTHESIA AND PAIN MEDICINE

Opioid Substitution to Improve the Effectiveness of Chronic Noncancer Pain Control: A Chart Review

Department of Anesthesiology, University of California San Diego, San Diego, California

Address correspondence and reprint requests to Mark S. Wallace, MD, UCSD Pain Management Medical Group, 9500 Gilman Dr. #0924, La Jolla, CA 92093-0924.

We evaluated the efficacy and tolerability of opioids in the long-term management of chronic noncancer pain. This retrospective chart review included 86 outpatients who started receiving, between 1994 and 1998, long-acting opioids. For each patient, the number of different opioids used and the efficacy and tolerability of each opioid prescribed were noted. During a mean follow-up of 8.8 ± 6.3 mo, the number of opioids used by each patient was 2.3 ± 1.4. Patient diagnoses were: back pain (31), neuropathy (20), joint pain (13), visceral pain (7), reflex sympathetic dystrophy (7), headache (5), fibromyalgia (3). The first opioid prescribed was effective for 36% of patients, was stopped because of side effects in 30%, and was stopped for ineffectiveness in 34%. Of the remaining patients, the second opioid prescribed after the failure of the first was effective in 31%, the third in 40%, the fourth in 56%, and the fifth in 14%. There was one case of addiction and no case of tolerance. We conclude that if it is necessary to change the opioid prescription because of intolerable side effects or ineffectiveness, the cumulative percentage of efficacy increases with each new opioid tested. Failure of one opioid cannot predict the patient’s response to another.

Implications: This study showed that if a patient receiving chronic opioid therapy experiences an intolerable side effect or if the drug is ineffective, changing to a different opioid may result in a lessening or elimination of the side effect and/or improved analgesia.

This article has been cited by other articles:

				H. S. Smith Opioid Metabolism Mayo Clin. Proc., July 1, 2009; 84(7): 613 - 624. [Abstract] [Full Text] [PDF]

				H. Ahdieh and R. White Comment: Oral Oxymorphone for Pain Management Ann. Pharmacother., December 1, 2007; 41(12): 2074 - 2074. [Full Text] [PDF]

				J. Rasor and G. Harris Using Opioids for Patients With Moderate to Severe Pain J Am Osteopath Assoc, September 1, 2007; 107(suppl_5): ES4 - ES10. [Abstract] [Full Text] [PDF]

				R. Sinatra Opioid Analgesics in Primary Care: Challenges and New Advances in the Management of Noncancer Pain J Am Board Fam Med, March 1, 2006; 19(2): 165 - 177. [Abstract] [Full Text] [PDF]

				J. Rasor III and G. Harris Opioid Use for Moderate to Severe Pain J Am Osteopath Assoc, June 1, 2005; 105(6_suppl_3): S2 - S7. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999